glp-1 and intermittent fasting + Injections: Smart or Dangerous? | Blog GLP-1 and Intermittent Fasting Together

A notable research effort, known as the STEP (Semaglutide GLP-1 Treatment Effect in People with Obesity) trial, revealed that participants taking Semaglutide GLP-1 achieved an average weight reduction of around 15% of their starting body weight within 68 weeks, unlike those taking a placebo

While omics and systems biology approaches offer valuable molecular insights, linking these findings to clinical outcomes remains a significant challenge

Leisman said in a comment on the post-publication peer review site PubPeer that he does not have a financial relationship with Brain Balance

These compounds are intended for research use

Exercise and training Resistance training is non-negotiable with either compound if you care about body composition rather than just the number on the scale

One of my patients, a 51yearold woman struggling with postmenopausal weight gain and fatigue, had tried countless diets